Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06066996 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of the Electronic Cigarette Withdrawal Syndrome
A Early Phase 1 study of E-cigarette Use and Withdrawal, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06066996 is a Early Phase 1 study of E-cigarette Use and Withdrawal that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 150 participants, below the 192-participant average among 12 other E-cigarette Use trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06066996, a Early Phase 1 study of E-cigarette Use and Withdrawal, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to rigorously evaluate the nature of e-cigarette withdrawal in exclusive e-cigarette users during a monitored abstinence period and the role of nicotine in the expression of this withdrawal syndrome.
Conditions Studied
Interventions
- DRUG Transdermal Nicotine Patch
- DRUG Placebo Nicotine Patch
Study Locations (1)
Maryland
- Behavioral Pharmacology Research Unit - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-11-28 |
| Est. Completion | 2028-06-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06066996
The ClinicalTrials.gov registry entry for NCT06066996 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 192-participant average among 12 other E-cigarette Use trials with a reported enrollment target (22% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with E-cigarette Use appearing as the primary indexed condition, and to 2 interventions - of which Transdermal Nicotine Patch is the first listed.
NCT06066996 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06066996 about?
NCT06066996 is a clinical study titled "Evaluation of the Electronic Cigarette Withdrawal Syndrome". The goal of this project is to rigorously evaluate the nature of e-cigarette withdrawal in exclusive e-cigarette users during a monitored abstinence period and the role of nicotine in the expression of this withdrawal syndrome.
What is the current status of trial NCT06066996?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 150 participants. The study started on 2023-11-28. Estimated completion is 2028-06-30.
What conditions does trial NCT06066996 study?
This clinical trial studies the following conditions: E-cigarette Use, Withdrawal.
What interventions are being tested in trial NCT06066996?
The interventions under investigation include: Transdermal Nicotine Patch (DRUG), Placebo Nicotine Patch (DRUG).
Who is sponsoring clinical trial NCT06066996?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06066996 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for E-cigarette Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sex Differences in the Vascular Effects of E-cigarette Use
RECRUITING · Early Phase 1
-
A Trial of Varenicline for E-cigarette Cessation
RECRUITING · Phase 2
-
Vape-Free Text-Messaging: Pilot Study
RECRUITING · NA
-
Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing
RECRUITING · NA
-
Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
RECRUITING · NA
-
An Online Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young Adults
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.